Dose-dependent in vivo effect of Rhodiola and Echinacea on the mitogen-induced lymphocyte proliferation in mice

• Autorzy: Skopińska-Rozewska E. , Sokolnicka I. , Siwicki A. K. , Stankiewicz W. , Dabrowski M. P. , Buchwald W. , Krajewska-Patan A. , Mielcarek S. , Mscisz A. , Furmanowa M.
• Języki publikacji: EN

Abstrakty

EN

Echinacea purpurea (EP) and Echinacea angustifolia (EA) are ones of the most important world’s herbs with immunotropic activity. They were traditional medicinal plants used by North American Indians for the treatment of various illnesses. Now they are cultivated in many countries and are used mainly to treat respiratory tract infections. Rhodiola rosea (RR) and Rhodiola quadrifida (RQ) are medicinal plants originated from Asia and used traditionally as adaptogens, antidepressants, and anti-inflammatory remedies. We previously reported, that extracts of underground parts of RR and RQ exhibited immunotropic activity. We have demonstrated in pigs that in vitro RR or RQ supplementation of blood lymphocyte cultures stimulated T cell proliferative response to Con A in lower, and inhibited it in higher Rhodiola extract concentrations. The aim of this work was to evaluate the in vivo effect of these herbal remedies on the in vitro proliferative response of mouse splenic lymphocytes to another T-cell mitogen- Phaseolus vulgaris haemagglutinin (PHA). We have found significant stimulation of proliferative response, in comparison to the controls, in mice fed lower doses of tested remedies, and inhibition, no effect or lower stimulation, in mice fed higher doses of these drugs.

Słowa kluczowe

EN

in vivo effect; Rhodiola rosea; Echinacea purpurea; Echinacea angustifolia; Rhodiola quadrifida; mitogen-induced lymphocyte; lymphocyte; proliferation; mice; mouse

• Wydawca: -
• Czasopismo: Polish Journal of Veterinary Sciences
• Rocznik: 2011
• Tom: 14
• Numer: 2
• Opis fizyczny: p.265-272,fig.,ref.

Twórcy

autor

Skopińska-Rozewska E.

• Department of Pathology, Biostucture Center, Warsaw Medical University, Chalubinskiego 5, 02-004 Warsaw, Poland

autor

Sokolnicka I.

autor

Siwicki A. K.

autor

Stankiewicz W.

autor

Dabrowski M. P.

autor

Buchwald W.

autor

Krajewska-Patan A.

autor

Mielcarek S.

autor

Mscisz A.

autor

Furmanowa M.

Bibliografia

• Bany J, Siwicki AK, Zdanowska D, Sokolnicka I, Skopinska-Różewska E, Kowalczyk M (2003) Echinacea purpurea stimulates cellular immunity and anti- bacterial defence independently of the strain of mice. Pol J Vet Sci 6 (Suppl): 3-5.
• Blomkvist J, Taube A, Larhammar D (2009) Perspective on Roseroot (Rhodiola rosea) studies. Planta Med 75: 1187-1190.
• Burger RA, Torres AR, Warren RP, Caldwell VD, Hughes BG (1997) Echinacea-induced cytokine production by human macrophages. Int J Immunopharmacol 19: 371-379.
• Clifford LJ, Nair MG, Rana J, Dewitt DL (2002) Bioactivity of alkamides isolated from Echinacea purpurea (L) Moench. Phytomedicine 9: 249-253.
• Dąbrowski MP, Stankiewicz W, Płusa T, Chciałowski A, Szmigielski S (2001) Competition of IL-1 and IL-1ra determines lymphocyte response to delayed stimulation with PHA. Mediators Inflamm 10: 101-107.
• Dong GC, Chuang PH, Forrest MD, Lin YC, Chen HM (2006) Immuno-suppressive effect of blocking the CD28 signaling pathway in T-cells by an active component of Echinacea found by a novel pharmaceutical screening method. J Med Chem 49: 1845-1854.
• Dong GC, Chuang PH, Chang KC, Jan PS, Hwang PI, Wu HB, Yi M, Zhou HX Chen HM (2009) Blocking effect of an immune-suppressive agent, cynarin, on CD28 of T-cell receptor. Pharm Res 26: 375-381.
• EMEA (2000) http://www.eudra.org/emea.html
• Ernst E (2002) The risk-benefit profile of commonly used herbal therapies: Gingko, St. John’s Wort, Ginseng, Echinacea, Saw Palmetto, and Kava. Ann Intern Med 136: 42-53.
• Furmanowa M, Skopińska-Różewska E, Rogala E, Hartwich M (1988) Rhodiola rosea in vitro culture- phytochemical analysis and anti-oxidant action. Acta Societ Botanic Poloniae 6: 69-73.
• Furmanowa M, Kędzia B, Hartwich M, Kozłowski J, Krajewska-Patan A, Mścisz A, Jankowiak J (1999) Phytochemical and pharmacological properties of Rhodiola rosea L. Herba Polonica 45: 108-113.
• Gertsch J, Schoop R, Kuenzle U, Suter E (2004) Echinacea alkylamides modulate TNF-alpha gene expression via cannabinoid receptor CB2 and multiple signal transduction pathways. FEBS Lett 577: 563-569.
• Hallgren HM, Yunis EJ (1977) Suppressor lymphocytes in young and aged humans. J Immunol 118: 2004-2008.
• Hostettmann K (2003) History of a plant: the example of Echinacea. Forsch Komplementarmed Klass Naturheilkd 10 (Suppl 1): 9-12.
• Hung SK, Perry R, Ernst E (2011) The effectiveness and efficacy of Rhodiola rosea L.: A systematic review of randomized clinical trials. Phytomedicine 18: 235-244.
• JeongHJ,Ryu YB, Park SJ, KimJH, Kwon HJ,Kim JH, Parh KH, Rho MC, Lee WS (2009) Neuraminidase inhibitory activities of flavonols isolated from Rhodiola rosea roots and their in vitro anti-influenza viral activities. Bioorg Med Chem 17: 6816-6823.
• Joksic G, Petrovic S, Joksic I, Leskovac A (2009) Biological effects of Echinacea purpurea on human blood cells. Art Hig Rada Toksikol 60: 165-172.
• Kim JB, Price RK, Stein RC, O’Hara MJ (2005) Risks of the complementary medicine Rhodiola rosea in breast cancer. J Nutrition (suppl) 135: 3048-3049.
• Kovaru H, Kovaru F, Pav M, Dvorak R, Palikova M, Raboch J, Zidkova J (2010) Effect of mitogen lectin on lymphocyte or brain cortex cell activation. Neuro Endocrinol Lett 31: 325-329.
• Mielcarek S, Mścisz A, Buchwald W, Krajewska-Patan A, Furmanowa M, Skopińska-Różewska E, Łuczkowska T, Mrozikiewicz PM (2005) Phytochemical investigation of Rhodiola sp. Root extracts. Herba Polonica 51 (Suppl 1): 159.
• Mierzwińska-Nastalska E, Demkow U, Siwicki AK, Nartowska J, Augustynowicz J, Skopińska-Różewska E (2005) The effect of Echinacea purpurea extract “Echinapur” on the angiogenic and chemokinetic activity of human leukocytes. Pol J Environm Studies 14 (Suppl 2): 639-642.
• Min BS, Bae KH, Kim YH (1999) Screening of Korean plants against human immunodeficiency virus (HIV-1) protease. Phytother Res 13: 680-682.
• Ming DS, Hillhouse BJ, Guns ES, Eberding A, Xie S, Vimalanathan S, Towers GH (2005) Bioactive compounds from Rhodiola rosea (Crassulaceae). Phytother Res 19: 740-743.
• Neveu PJ, Taghzouti K, Dantzer R, Simon H, Le Moal M (1986) Modulation of mitogen-induced lymphoproliferation by cerebral neocortex. Life Sci 38: 1907-1913.
• O’Neill W, McKee S, Clarke AF (2002) Immunological and haematinic consequences of feeding a standardized Echinacea (Echinacea angustifolia) extract to healthy horses. Equine Vet J 34: 222-227.
• Panossian A, Wikman G, Sarris J (2010) (Rosenroot (Rhodiola rosea): traditional use, chemical composition, pharmacology and clinical efficacy. Phytomedicine 17: 481-493.
• Pecanha LM, Dos Reis GA (1989) Murine polyclonal T-lymphocyte activation induced by phytohemagglutinin; differential lymphokine requirements of two unusual activation pathways defined by resistance to blockade by barium and by cyclosporine A. Int J Immunopharmacol 11: 149-156.
• Reinke RA, Lee DJ, McDougall BR, King PJ, Victoria J, Mao Y, Lei X, Reinecke MG, Robinson WE Jr (2004) L-chicoric acid inhibits human immunodeficiency virus (HIV-1) integration in vivo and is a noncompetitive but reversible inhibitor of HIV-1 integrase in vitro. Virology 326: 203-219.
• Robinson WE Jr (1998) L-chicoric acid, an inhibitor of human immunodeficiency virus (HIV-1) integrase, improves on the in vitro anti-HIV-1 effect of Zidovudine plus a protease inhibitor (AG1350). Antiviral Res 39: 101-111.
• Rogala E, Skopińska-Różewska E, Wasiutyński A, Siwicki AK, Sommer E, Pastewka K (2008) Echinacea purpurea diminishes neovascular reaction induced in mice skin by human cancer cells and stimulates non-specific cellular immunity in humans. Centr Eur J Immunol 33: 127-130.
• See DM, Broumand N, Sahl L, Tilles JG (1997) In vitro effects of Echinacea and Ginseng on natural killer and antibody-dependent cell cytotoxicity in healthy subjects and chronic fatigue syndrome or acquired immunodeficiency syndrome patients. Immunopharmacology 35: 229-235.
• Sloley BD, Urichuk LJ, Tywin C, CouttsRT, Pang PKT, Shan JJ (2001) Comparison of chemical components and antioxidant capacity of different Echinacea species. J Pharm Pharmacol 53: 849-857.
• Siwicki AK, Skopińska-Różewska E, Hartwich M , Wójcik R, Bakuła T, FurmanowaM, Bałan BJ, Sommer E, Mielcarek S, Buchwald W, Krajewska-Patan A, Mścisz A, Mrozikiewicz PM, Bany J (2007) The influence of Rhodiola rosea extracts on non-specific and specific cellular immunity in pigs, rats and mice. Centr Eur J Immunol 32: 84-91.
• Skopińska-Różewska E, Wojtasik E (2002) Immunotropowe działanie jeżówek. In: Skopińska-Różewska E (ed) Wpływ substancji naturalnych na układ odpornościowy. Wydawnictwo. Fundacja Pomocy Zdrowiu, Warszawa, pp 32-42.
• Skopińska-Różewska E, Sokolnicka I, Radomska-Leśniewska D, Kapałka B, Sommer E, Białas-Chromiec B, Filewska M, Demkow U (2003) The in vivo effect of Echinacea purpurea succus on various functions of human blood leukocytes. Centr Eur J Immunol 28: 126-130.
• Skopińska-Różewska E, Wójcik R, Siwicki AK, Sommer E, Wasiutyński A, Furmanowa M, Malinowski M, Mazurkiewicz M (2008a) The effect of Rhodiola quadrifida extracts on cellular immunity in mice and rats. Pol J Vet Sci 11: 105-111.
• Skopinska-Rozewska E, Strzelecka H, Wasiutynski A, Balan BJ, Nartowska J, Mazurkiewicz M, Sommer E, Bany J (2008b) Aqueous and hydro-alcoholic extracts of Echinacea purpurea (L) Moench as traditional herbal remedies with immunotropic activity. Centr Eur J Immunol 33: 78-82.
• Skopińska-Różewska E, Bychawska M, Białas-Chromiec B, Sommer E (2009) The in vivo effect of Rhodiola rosea and Rhodiola quadrifida hydro-alcoholic extracts on chemokinetic activity of spleen lymphocytes in mice. Centr Eur J Immunol 34: 42-45.
• Skopińska-Różewska E, Sommer E, Bałan BJ, Borowska A, Radomska-Leśniewska D (2010) The In vivo effect of dry hydro-alcoholic extract of Echinacea purpurea on angiogenic activity of human blood mononuclear cells. Centr Eur J Immunol 35: 223-226.
• Spelman K, Iiams-Hauser K, Cech NB, Taylor EW, Smirnoff N, Wenner CA (2009) Role for PPARgamma in IL-2 inhibition in T cells by Echinacea-derived undeca– 2E-ene-8,10-diynoic acid isobutylamide. Int Immunopharmacol 9: 1260-1264.
• Tsien RY, Pozzan T, Rink TJ (1982) T-cell mitogens cause early changes in cytoplasmic free Ca²⁺ and membrane potential in lymphocytes. Nature 295: 68-71.
• Wang T, Sheppard JR, Foker JE (1978) Rise and fall of cAMP required for onset of lymphocyte DNA synthesis. Science 201: 155-157.
• Wiedenfeld H, Dumaa M, Malinowski M, Furmanowa M, Narantuya S (2007) Phytochemical and analytical studies of extracts from Rhodiola rosea and Rhodiola quadrifida. Pharmazie 62: 308-311.
• Wójcik R, Siwicki AK, Skopińska-Różewska E, Buchwald W, Furmanowa M (2009a) The In vitro influence of Rhodiola kirilowii extracts on blood granulocytes potential killing activity (PKA) in pigs. Centr Eur J Immunol 34: 158-161.
• Wójcik R, Siwicki AK, Skopińska-Różewska E, Bakuła T, Furmanowa M (2009b) The In vitro effect of Rhodiola quadrifida and Rhodiola kirilowii extracts on pigs blood lymphocyte response to mitogen Concanavalin A. Centr Eur J Immunol 34: 166-170.